Thus, we uncovered a novel mechanism of CRC growth and metastasis regulated by CLDN2/ZO1/ZONAB‐NDRG1 axis, indicating CLDN2/ZO1/ZONAB‐NDRG1 axis could serve as a promising therapeutic target for CRC. This evidence concerns the gene YBX3 and colorectal carcinoma.